References
- Barron D, Ibrahim RK (1996): Isoprenylated flavonoids — a survey. Phytochemistry 43: 921–982.
- Comte G, Daskiewicz JB, Barron D, Bayet C, Conseil G, Viornery-Vanier A, Dumontet C, Di Pietro A (2001): C-alkylation of flavonoids enhances binding affinity towards P-glycoprotein and modulation of cancer cell chemoresis-tance. J Med Chem 44: 763–768.
- Conseil G, Baubichon-Cortay H, Dayan G, Jault JM, Barron D, Di Pietro A (1998): Flavonoids: a class of modulators with bifunctional interactions at vicinal ATP- and steroid binding sites on mouse P-glycoprotein. Proc Natl Acad Sci USA 95: 9831–9836.
- Divita G, Goody RS, Gautheron DC, Di Pietro A (1993): Struc-tural mapping of catalytic site with respect to alpha-subunit and noncatalytic site in yeast mitochondrial F 1 -ATPase using fluorescence resonance energy transfer. J Biol Chem 268: 13178–13186.
- Goldstein LJ (1995): Clinical reversal of drug resistance. Curr Probl Cancer 19: 65–124.
- Gottesman MM, Pastan I (1993): Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 62: 385–427.
- Hyde SC, Emsley P, Hartshorn MJ, Mimmack Mlvi, Gileadi U, Pearce SR, Gallagher MP, Gill DR, Hubbard RE, Higgins CF (1990): Structural model of ATP-binding proteins asso-ciated with cystic fibrosis, multidrug resistance and bacte-rial transport. Nature (Lond) 346: 362–365.
- Jearmesson P, Trentesaux C, Gerard B, Jardillier JC, Ross KL, Tokes ZA (1990): Induction of erythroid differentiation in human leukemic K-562 cells by membrane-directed action of adriamycin covalently bound to microspheres. Cancer Res 50: 1231–1236.
- Kellen (1993): The reversal of multidrug resistance in cancer. Anticancer res 13: 959–961.
- Lehriert M (1994): Multidrug resistance in human cancer. J Neuro-oncol 22: 239–243.
- Lehriert M (1998): Chemotherapy resistance in breast cancer. Anticancer Res 18: 2225–2226.
- Licht T, Pastan I, Gottesman MM, Herrmann F (1996): The multidrug-resistance gene in gene therapy of cancer and hematopoietic disorders. Ann Hematol 72: 184–193.
- Loor F, Boesch D, Gaveriaux C, Jachez B, Pourtier-Manzanedo A, Emmer G (1992): SDZ 280–446, a novel semi-synthetic cyclopeptolide: in vitro and in vivo circumvention of the P-glycoprotein mediated tumour cell multidrug resistance. Br J Cancer 65: 11–18.
- Tsuruo T, Lida H, Tsukayoshi S, Sakurai Y (1981): Overcom-ing of vincristine resistance in P388 leukaemia in vivo and in vitro through enhanced cytotoxicity of vincristine and vinblastine by verapamil. Cancer Res 41: 1967–1972.
- Twentyman PR, Bleehen NM (1991): Resistance modification by PSC-833, a novel non-immunosuppressive cyclosporin A. Eur J Cancer 27: 1639–1642.
- Yoshimura A, Shudo N, Ikeda SI, Sumizawa T, Akiyama SI (1990): Novel screening method for agents that overcome classical multidrug resistance in a human cell line. Cancer Lett 50: 45–51.